share_log

維亞生物:(1) 與朗華製藥80%股權有關的非常重大收購事項;及 (2) 二零二零年第二次股東特別大會通告

Viva Biotech Holdings: (1) VERY SUBSTANTIAL ACQUISITION IN RELATION TO 80% OF THE EQUITY INTEREST OF LANGHUA PHARMACEUTICAL; AND (2) NOTICE OF SECOND EXTRAORDINARY GENERAL MEETING IN 2020

Oct 16, 2020 08:35
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more